Table 1.
Demographics and Clinical Characteristics of Patients with COVID-19 ARDS and non-COVID-19 ARDS*
| Patient Code | Respiratory infection | Age | Sex | Comorbidities | Intubated (days) |
|---|---|---|---|---|---|
| ARDS-201 | Aspiration pneumonia | 74 | F | CAD, DM2, HTN, Breast cancer, Dementia | 25 |
| ARDS-3 | Bacterial pneumonia | 77 | M | CAD, DM1, PE, Dementia | None |
| ARDS-4 | Bacterial pneumonia | 39 | F | Sjogren’s syndrome | 3 |
| ARDS-5 | Bacterial pneumonia | 34 | M | CAD, Gastric cancer | 15 |
| ARDS-203 | Bacterial pneumonia, Influenza | 47 | F | DM2, HTN, Hypothyroidism | 4 |
| COVID-10 | SARS-CoV-2 pneumonia | 56 | F | DM2, HTN, Sickle cell anemia | None |
| COVID-11 | SARS-CoV_2 pneumonia | 75 | M | HTN, Lung cancer | 25 |
| COVID-14 | SARS-CoV-2 pneumonia | 70 | M | Arteritis | None |
| COVID-19 | SARS-CoV-2 pneumonia | 70 | M | Unknown | None |
| COVID-20 | SARS-CoV-2 pneumonia | 30 | F | Diabetes, Pulmonary valve atresia | 12 |
| COVID-30 | SARS-CoV-2 pneumonia | 52 | M | CAD, HDK, DM2 | 29 |
| COVID-7 | SARS-CoV-2 pneumonia | 69 | M | DM2, AML | None |
| COVID-2 | SARS-CoV-2 pneumonia | 73 | M | Pre-Diabetes, COPD | 5 |
| COVID-3 | SARS-CoV-2 pneumonia | 71 | M | Diabetes, HTN | None |
| COVID-8 | SARS-CoV-2 pneumonia | 46 | M | DM2, HTN, Asthma | 7 |
| COVID-OK | SARS-CoV-2 Pneumonia, cardiac arrest | 77 | M | HTN, splenectomy | None |
*
CAD, coronary artery disease; DM2, type 2 diabetes mellitus; PE, pulmonary embolism; DM1, type 1 diabetes mellitus; COPD, chronic obstructive pulmonary disease; AML, acute myelogenous leukemia; HTN, hypertension; HLD, hyperlipidemia.